(22S)-Budesonide

IMPURITIES

Product Details

CAT No.# CS-T-49951
Category Impurities
CAS 51372-28-2
Molecular Weight 430.53
Molecular Formula C25H34O6
Stock Status: In-Stock
Purity: >98%
Melting Point: 196-198
Solubility: Chloroform, Methanol
Appearance: Off-White Solid
Synonyms: (22S)-Budesonide;22(S)Budesonide Peak II;(11,16a)-
Application Notes: Budesonide epimer S. Budesonide 22R epimer is more active than 22S epimer.
References: Ryrfeldt., A., et a.: J. Steroid Biochem., 10, 317 (1979), Roth, G., et al.: J. Pharm. Sci., 69, 766 (1980), Clissold, S.P., et al.: Drugs, 28, 485 (1984),
Storage: -20°C Freezer
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
(22S)-Budesonide Worldwide Suppliers of (22S)-Budesonide Impurities Clearsynth CS-T-49951

Product rating: 9 (22S)-Budesonide based on 20 ratings

  1. Impurities
  2. (22S)-Budesonide

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B


Smileys:
O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C5)(O[C@@H](CCC)O1)[C@]25C)CO



This page contains information about (22S)-Budesonide Cas 51372-28-2 and its Impurities.

(22S)-Budesonide (22S)-Budesonide Worldwide Suppliers of (22S)-Budesonide Impurities Clearsynth 51372-28-2

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."